Biotech China 2014

Pharmacology: GlaxoSmithKline

Total Score People Score Events Score
11 11 8
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Dashyant Dhanak
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC Tona M Gilmer, Axel Hoos
March 7, 2011 Imaging in Cancer Drug Development The role of PET in drug development Jan Passchier
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer GSK2126458: A potent inhibitor of PI3K and mTOR Richard WOOSTER
February 23, 2009 Advances and Progress in Drug Design VIII STRUCTURE BASED DRUG DESIGN WITH EMPHASIS ON GPCR MODELLING Frank Blaney
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Drug Induced Vascular Injury Brian R. Berridge
Can Plasma Protein Binding Represent a Safety Issue for Drug Development? The Radafaxine Case Paolo Rossato
October 8, 2008 Accelerating Proof Of Concept Implementing New Approaches for Increasing Productivity of Drug Development Dongzhou J. Liu
November 7, 2007 Stem Cells and Primary Cells in Drug Discovery Welcome Remarks Robert Ames
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) Dana E. Vanderwall
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Analysis of Biological Mechanism of Action, and Characterization of Profiles across the Progression Path (14:05-14:35) Dana E. Vanderwall
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.